Effector Mechanisms of Fenretinide-Induced Apoptosis in Neuroblastoma
Authors:
- Penny E. LovatPLPenny E. Lovat
- Marco RanallicMRMarco Ranallic
- Margherita Annichiarrico-PetruzzelliMAMargherita Annichiarrico-Petruzzelli
- Francesca BernassolacFBFrancesca Bernassolac
- Mauro PiacentinideMPMauro Piacentinide
- Archie J. MalcolmAMArchie J. Malcolm
- Andy D.J. PearsonAPAndy D.J. Pearson
- Gerry MelinocGMGerry Melinoc
- Christopher P.F. RedfernCRChristopher P.F. Redfern
- 1 October 2000
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 260 (1) , 50-60
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Fenretinide: the Death of a Tumor CellJNCI: Journal of the National Cancer Institute, 1999
- Molecular Biology of NeuroblastomaJournal of Clinical Oncology, 1999
- Caspases: the executioners of apoptosisBiochemical Journal, 1997
- Apoptosis of N-Type Neuroblastoma Cells After Differentiation With 9-cis-Retinoic Acid and Subsequent WashoutJNCI: Journal of the National Cancer Institute, 1997
- Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell LinesJNCI: Journal of the National Cancer Institute, 1995
- Neuroblastoma cell apoptosis induced by the synthetic retinoid N‐(4‐hydroxyphenyl)retinamideInternational Journal of Cancer, 1994
- Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.Molecular and Cellular Biology, 1994
- N-(4-hydroxyphenyl)retinamide: a Potent Inducer of Apoptosis in Human Neuroblastoma CellsJNCI: Journal of the National Cancer Institute, 1994
- Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary resultsOral Oncology, 1992